These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 21122628)
21. The effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome. Snel M; Sleddering MA; Pijl H; Nieuwenhuizen WF; Frölich M; Havekes LM; Romijn JA; Jazet IM Eur J Clin Nutr; 2010 Apr; 64(4):419-23. PubMed ID: 20179727 [TBL] [Abstract][Full Text] [Related]
22. Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women. Shidfar F; Ehramphosh E; Heydari I; Haghighi L; Hosseini S; Shidfar S Int J Food Sci Nutr; 2009 May; 60(3):195-205. PubMed ID: 18608549 [TBL] [Abstract][Full Text] [Related]
23. Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease. Earnest CP; Mikus CR; Lemieux I; Arsenault BJ; Church TS Nutrition; 2007 Sep; 23(9):625-33. PubMed ID: 17644340 [TBL] [Abstract][Full Text] [Related]
24. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Weggemans RM; Trautwein EA Eur J Clin Nutr; 2003 Aug; 57(8):940-6. PubMed ID: 12879088 [TBL] [Abstract][Full Text] [Related]
25. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Washburn S; Burke GL; Morgan T; Anthony M Menopause; 1999; 6(1):7-13. PubMed ID: 10100174 [TBL] [Abstract][Full Text] [Related]
27. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Persson M; Hedblad B; Nelson JJ; Berglund G Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184 [TBL] [Abstract][Full Text] [Related]
28. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria. Gazi I; Tsimihodimos V; Filippatos T; Bairaktari E; Tselepis AD; Elisaf M Metabolism; 2006 Jul; 55(7):885-91. PubMed ID: 16784959 [TBL] [Abstract][Full Text] [Related]
29. Low high density lipoprotein cholesterol: prevalence and associated risk-factors in a large French population. Rouvre M; Vol S; Gusto G; Born C; Lantieri O; Tichet J; Lecomte P Ann Epidemiol; 2011 Feb; 21(2):118-27. PubMed ID: 21184952 [TBL] [Abstract][Full Text] [Related]
30. [Clinical aspects of phytosterols in human nutrition]. Stelmach-Mardas M; Przysławski J Forsch Komplementmed; 2013; 20(3):213-8. PubMed ID: 23860023 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial. Lerman RH; Minich DM; Darland G; Lamb JJ; Schiltz B; Babish JG; Bland JS; Tripp ML Nutr Metab (Lond); 2008 Nov; 5():29. PubMed ID: 18983673 [TBL] [Abstract][Full Text] [Related]
32. Viscous fibers, health claims, and strategies to reduce cardiovascular disease risk. Jenkins DJ; Kendall CW; Vuksan V Am J Clin Nutr; 2000 Feb; 71(2):401-2. PubMed ID: 10648250 [No Abstract] [Full Text] [Related]
33. Focus on lifestyle: EAS Consensus Panel Position Statement on Phytosterol-added Foods. Stock J Atherosclerosis; 2014 May; 234(1):142-5. PubMed ID: 24637414 [No Abstract] [Full Text] [Related]
34. Optimized mixture of hops rho iso-alpha acids-rich extract and acacia proanthocyanidins-rich extract reduces insulin resistance in 3T3-L1 adipocytes and improves glucose and insulin control in db/db mice. Tripp ML; Darland G; Konda VR; Pacioretty LM; Chang JL; Bland JS; Babish JG Nutr Res Pract; 2012 Oct; 6(5):405-13. PubMed ID: 23198019 [TBL] [Abstract][Full Text] [Related]
35. [Clinical significance of remnant lipoprotein in metabolic syndrome]. Yamane K Nihon Rinsho; 2006 Dec; 64 Suppl 9():400-3. PubMed ID: 17458252 [No Abstract] [Full Text] [Related]
36. Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: evidence and controversies. Johri AM; Heyland DK; Hétu MF; Crawford B; Spence JD Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):808-14. PubMed ID: 24837277 [TBL] [Abstract][Full Text] [Related]
37. Hop and Acacia Phytochemicals Decreased Lipotoxicity in 3T3-L1 Adipocytes, db/db Mice, and Individuals with Metabolic Syndrome. Minich DM; Lerman RH; Darland G; Babish JG; Pacioretty LM; Bland JS; Tripp ML J Nutr Metab; 2010; 2010():. PubMed ID: 20721358 [TBL] [Abstract][Full Text] [Related]
38. Nutritional support in the pharmacological treatment of metabolic syndrome. Visioli F Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S43-9. PubMed ID: 21813086 [TBL] [Abstract][Full Text] [Related]
39. Plant sterols, health claims and strategies to reduce cardiovascular disease risk. Jenkins DJ; Kendall CW J Am Coll Nutr; 1999 Dec; 18(6):559-62. PubMed ID: 10613406 [No Abstract] [Full Text] [Related]
40. [Food additive (bifeinol, detovit, squalenol) in the treatment of patients with metabolic syndrome]. Panchenko VM; Ershov AA; Ionova IN; Obukhova OIu; Zimovchenko GS; Isaev VA Klin Med (Mosk); 2004; 82(7):59-61. PubMed ID: 15449778 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]